Tenderwize
Wróć do wyszukiwania

Discount agreement for Follitropin alfa biologics

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2028 · 705 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-25 - Follitropin alfa

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

The notice says offers/contracts cannot be submitted via the portal; they must be sent by email with qualified electron...

Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal products and requires the stated au...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 3 lots
  • Duration until Jul 2028
  • Open House discount agreements for pharmaceutical products under § 130a(8) SGB V for the active substance Follitropin alfa.
  • Three lots are formed for specific branded medicines: GONAL-f, Bemfola, and Ovaleap.
Pokaż pełne podsumowanie

Open House procedure by Techniker Krankenkasse for supply-side pharmaceutical discount agreements under § 130a(8) SGB V for the active substance Follitropin alfa. Three lots are listed for specific branded medicines (GONAL-f, Bemfola, Ovaleap). The procedure is non-exclusive, with no individual negotiations, and contracts may be concluded with all eligible pharmaceutical companies that meet the stated self-declarations and sign the contract in text form/electronic form as required. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. Procurement documents are available on the portal, but only extracted XML notice text was provided here, not the full document set.

Ryzyka

The notice says offers/contracts cannot be submitted via the portal; they must be sent by email with qualified electron...

Participation is limited to pharmaceutical entrepreneurs for the relevant medicinal products and requires the stated au...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Tenderer must be a pharmaceutical entrepreneur within the meaning of § 4(18) AMG for the offered medicinal product(s).
  • Tenderer must have its registered seat in the AMG territory, another EU Member State, or another EEA state.
  • Tenderer must hold a valid marketing authorisation for the relevant medicinal product(s) or otherwise be entitled to place them on the market in its own name.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (3)

LOT-0001

Follitropin alfa (GONAL-f)

Supply lot for Follitropin alfa covering the branded medicinal product GONAL-f. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jul 2026 - Jul 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jul 30, 2028

LOT-0002

Follitropin alfa (Bemfola)

Supply lot for Follitropin alfa covering the branded medicinal product Bemfola. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jul 2026 - Jul 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jul 30, 2028

LOT-0003

Follitropin alfa (Ovaleap)

Supply lot for Follitropin alfa covering the branded medicinal product Ovaleap. The lot is part of an Open House discount agreement scheme; no exclusivity and no individual negotiations apply. Performance is nationwide in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jul 2026 - Jul 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jul 30, 2028

Szczegóły zamówienia

Data publikacji
07 Jun 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
388432-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3